Health
Cigarette maker BAT announces US vaccine trial launch – Medical Xpress
British cigarette maker BAT said Wednesday that its US biotech division Kentucky BioProcessing will launch trials of a potential coronavirus vaccine, developed…
British cigarette maker BAT said Wednesday that its US biotech division Kentucky BioProcessing will launch trials of a potential coronavirus vaccine, developed using tobacco plant technology.
The group said the US Food and Drug Administration has approved its application for a vaccine candidate, paving the way for an initial phase one clinical trial in 180 adults.
Study results are expected in mid-2021, when the group hopes to progress to a phase two trial on the project, which is being run on a…
-
Noosa News21 hours agoAre speeding fines suitability issues? – Proctor
-
Noosa News23 hours agoElderly man, 88, charged with attempted murder of woman west of Brisbane
-
Noosa News22 hours agoFrom Cosy Hotel Stays To New Exhibitions: How To Master a Sydney Winter Escape
-
Business23 hours ago10 reasons to buy and hold this tech stock forever